Health ❯ Nutrition ❯ Weight Management ❯ Pharmaceuticals

Clinical Trials

FDA Approves First Oral GLP-1 for Obesity as Novo’s Wegovy Pill Sets January U.S. Launch

The pill debuts with a $149 introductory cash price for the starter dose under a White House arrangement.

Meta-Analysis Finds GLP-1 Drugs Show Little Short-Term Impact on Obesity-Linked Cancer Risk